255 related articles for article (PubMed ID: 18415816)
1. Utility of biochemical markers of bone turnover and bone mineral density in management of osteoporosis.
Vasikaran SD
Crit Rev Clin Lab Sci; 2008; 45(2):221-58. PubMed ID: 18415816
[TBL] [Abstract][Full Text] [Related]
2. How useful are measures of BMD and bone turnover?
Miller PD; Hochberg MC; Wehren LE; Ross PD; Wasnich RD
Curr Med Res Opin; 2005 Apr; 21(4):545-54. PubMed ID: 15899103
[TBL] [Abstract][Full Text] [Related]
3. Use of biochemical markers of bone turnover in the management of postmenopausal osteoporosis.
Camacho PM; Lopez NA
Clin Chem Lab Med; 2008; 46(10):1345-57. PubMed ID: 18844486
[TBL] [Abstract][Full Text] [Related]
4. Biomarkers for osteoporosis management: utility in diagnosis, fracture risk prediction and therapy monitoring.
Garnero P
Mol Diagn Ther; 2008; 12(3):157-70. PubMed ID: 18510379
[TBL] [Abstract][Full Text] [Related]
5. Use of bone turnover markers in the management of osteoporosis.
Jain S; Camacho P
Curr Opin Endocrinol Diabetes Obes; 2018 Dec; 25(6):366-372. PubMed ID: 30299435
[TBL] [Abstract][Full Text] [Related]
6. [Clinical use of biological markers of bone turnover in osteoporosis].
Bergmann P
Rev Med Brux; 2008 Sep; 29(4):295-300. PubMed ID: 18949980
[TBL] [Abstract][Full Text] [Related]
7. Clinical use of biochemical markers of bone remodeling: current status and future directions.
Looker AC; Bauer DC; Chesnut CH; Gundberg CM; Hochberg MC; Klee G; Kleerekoper M; Watts NB; Bell NH
Osteoporos Int; 2000; 11(6):467-80. PubMed ID: 10982161
[TBL] [Abstract][Full Text] [Related]
8. Fast and slow bone losers. Relevance to the management of osteoporosis.
Hough S
Drugs Aging; 1998; 12 Suppl 1():1-7. PubMed ID: 9673860
[TBL] [Abstract][Full Text] [Related]
9. Risk assessment for osteoporosis. II. Biochemical markers of bone turnover: bone resorption indices.
Woitge HW; Seibel MJ
Clin Lab Med; 2000 Sep; 20(3):503-25, vi. PubMed ID: 10986618
[TBL] [Abstract][Full Text] [Related]
10. Early changes in biochemical markers of bone turnover predict bone mineral density response to antiresorptive therapy in Korean postmenopausal women with osteoporosis.
Kim SW; Park DJ; Park KS; Kim SY; Cho BY; Lee HK; Shin CS
Endocr J; 2005 Dec; 52(6):667-74. PubMed ID: 16410657
[TBL] [Abstract][Full Text] [Related]
11. Urinary Bone Turnover Markers as Target Indicators for Monitoring Bisphosphonate Drug Treatment in the Management of Osteoporosis.
Kwon S; Wang AH; Sadowski CA; Yuksel N; Doschak MR
Curr Drug Targets; 2018; 19(5):451-459. PubMed ID: 28676000
[TBL] [Abstract][Full Text] [Related]
12. [A comparison of the measurements with biochemical markers of bone turnover and bone mineral density in the assessment of the efficiency of osteoporosis treatment].
Ataoğlu MB; Atik OŞ; Gül O; Sarıkaya B; Görmeli G; Öztürk BY; Özgürol B
Eklem Hastalik Cerrahisi; 2013; 24(2):82-6. PubMed ID: 23692194
[TBL] [Abstract][Full Text] [Related]
13. Bone density change and biochemical indices of skeletal turnover.
Cosman F; Nieves J; Wilkinson C; Schnering D; Shen V; Lindsay R
Calcif Tissue Int; 1996 Apr; 58(4):236-43. PubMed ID: 8661954
[TBL] [Abstract][Full Text] [Related]
14. Contribution of bone mineral density and bone turnover markers to the estimation of risk of osteoporotic fracture in postmenopausal women.
Garnero P; Delmas PD
J Musculoskelet Neuronal Interact; 2004 Mar; 4(1):50-63. PubMed ID: 15615078
[TBL] [Abstract][Full Text] [Related]
15. Osteoporosis in men.
Korpi-Steiner N; Milhorn D; Hammett-Stabler C
Clin Biochem; 2014 Jul; 47(10-11):950-9. PubMed ID: 24726494
[TBL] [Abstract][Full Text] [Related]
16. Modeling and simulation of bone mineral density in Japanese osteoporosis patients treated with zoledronic acid using tartrate-resistant acid phosphatase 5b, a bone resorption marker.
Mori Y; Kasai H; Ose A; Serada M; Ishiguro M; Shiraki M; Tanigawara Y
Osteoporos Int; 2018 May; 29(5):1155-1163. PubMed ID: 29423715
[TBL] [Abstract][Full Text] [Related]
17. Early changes in biochemical markers of bone formation predict BMD response to teriparatide in postmenopausal women with osteoporosis.
Chen P; Satterwhite JH; Licata AA; Lewiecki EM; Sipos AA; Misurski DM; Wagman RB
J Bone Miner Res; 2005 Jun; 20(6):962-70. PubMed ID: 15883636
[TBL] [Abstract][Full Text] [Related]
18. Attainment of peak bone mass and bone turnover rate in relation to estrous cycle, pregnancy and lactation in colony-bred Sprague-Dawley rats: suitability for studies on pathophysiology of bone and therapeutic measures for its management.
Sengupta S; Arshad M; Sharma S; Dubey M; Singh MM
J Steroid Biochem Mol Biol; 2005 Apr; 94(5):421-9. PubMed ID: 15876407
[TBL] [Abstract][Full Text] [Related]
19. Regulatory Perspectives in Pharmacometric Models of Osteoporosis.
Madrasi K; Li F; Kim MJ; Samant S; Voss S; Kehoe T; Bashaw ED; Ahn HY; Wang Y; Florian J; Schmidt S; Lesko LJ; Li L
J Clin Pharmacol; 2018 May; 58(5):572-585. PubMed ID: 29485684
[TBL] [Abstract][Full Text] [Related]
20. [The role of biochemical markers of bone turnover in the diagnosis of osteoporosis and predicting fracture risk].
Mohamed Y; Haifa H; Datel O; Fadoua HN; Smeh BH; Mahbouba J; Saoussen Z; Bejia I; Mongi T; Mohamed FN; Naceur B
Tunis Med; 2014 May; 92(5):304-10. PubMed ID: 25504382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
